We're faced with many choices in the world today. We're all built with the instinct for fight or flight when faced with confrontation. A bully can gain courage if you don't have to meet in person.
Britain's two biggest police forces announced Wednesday that officers would take an "enhanced approach" to counter antisemitism, arresting protesters who use certain slogans and phrases, in response ...
In contrast to the more cautious posture of her predecessor Shigeru Ishiba, Japanese Prime Minister Sanae Takaichi’s diplomatic approach exudes a striking sense of confidence and theatricality.
Lymphocytic colitis is a bowel condition characterized by chronic, watery diarrhea and the buildup of white blood cells in your gut. It is most common in older adults. Lymphocytic colitis is a rare ...
Ann Arbor — Four games into his Michigan career, forward Yaxel Lendeborg is still figuring out his role on the team. But over the first two weeks of the regular season, the preseason All-American came ...
A toxin produced by bacteria found in dirty water kills off immune cells in the lining of the colon, meaning people whose guts are colonised by these bacteria are much more likely to develop a ...
“I often feel like I’m invisible,” a Dear David reader complains. “My colleagues don’t listen to my ideas and my friends take me for granted, but I’m afraid that if I express my frustration, it will ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Subcutaneous guselkumab induction and maintenance ...
As mentioned, Crohn’s colitis is a subtype of Crohn’s disease that only affects the colon. “We typically label Crohn’s based on what part of the gastrointestinal tract it affects,” says Sara ...
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that causes inflammation of the colon, and leads to symptoms such as fatigue, abdominal pain, and cramping. There is currently no cure ...
A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients for whom other treatments had failed and raising hopes for a safer, more ...
The FDA approved the TNF-alpha inhibitor golimumab (Simponi, Johnson & Johnson) to treat children with moderately to severely active ulcerative colitis (UC) weighing at least 15 kg. Of the more than 1 ...